Vigene Biosciences

Developer of life science research reagents for drug discovery and functional genomics

placeRockville, Maryland, United States calendar_todayFounded 2012 groups45 employees language vigenebio.com

Registered entities

Innovation

5 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 656 times.

YearFilings
20151
20203
20214

Investor mix

3 investors on record; lead investors include Signet Healthcare Partners; 1 has since exited.

Investor typeCountShare
Private equity267%
Bank & private debt133%
Coming soon